Radionics has received notification from the Food and Drug Administration that The Body System device has been cleared for marketing. Radionics is a unit of Tyco Healthcare Group LP, a division of Tyco International Ltd.
The Body System device immobilizes and localizes patients undergoing stereotactic radiation therapy treatments and is used in conjunction with Radionics' XPlan and IMRT treatment planning system. The Body System device makes it possible to reproduce the set-up of the patient receiving fractionated treatments and align the radiation beam precisely to the tumor volume thereby effectively treating the tumor while sparing the surrounding tissue.
Linda Finn, RTT, Clinical Research Specialist at Radionics, said, "The Body System device has an ease of use which makes it a valuable immobilization and localization tool for a busy clinic. The ability to immobilize and re-localize quickly and accurately is extremely important for sites performing Stereotactic Intensity Modulated Radiation Therapy (IMRT)."